Filtered By:
Vaccination: Covid Vaccine

This page shows you your search results in order of date. This is page number 2.

Order by Relevance | Date

Total 848 results found since Jan 2013.

HIV researcher will head NIH ’s infectious disease institute
The infectious disease institute at the U.S. National Institutes of Health (NIH) will soon have its first new chief in nearly 4 decades. Jeanne Marrazzo, an expert on sexually transmitted infections, will become director of the National Institute of Allergy and Infectious Diseases (NIAID) in the fall. She will succeed Anthony Fauci, who stepped down in December 2022 after 38 years at NIAID’s helm. Marrazzo, 61, currently directs the Division of Infectious Diseases at the University of Alabama at Birmingham (UAB). A physician and epidemiologist, she has expertise in HIV prevention, vaginal infections, horm...
Source: ScienceNOW - August 2, 2023 Category: Science Source Type: news

The U.S. Scientist At the Heart of COVID-19 Lab Leak Conspiracies Is Still Trying to Save the World From the Next Pandemic
Ralph Baric stepped onto the auditorium stage at the University of North Carolina, Chapel Hill, and looked out at the sparse audience that had come to hear him speak. On the large projector screen hanging behind him, the following words appeared: How Bad the Next Pandemic Could Be, What Might It Look Like, and Will We be Ready. The date was May 29, 2018. “Well, I have to admit I’m a little worried about giving this talk,” Baric said. “The reason is being labelled a harbinger of doom.” The screen shifted, and images of the four horsemen of the apocalypse—Death, Famine, War, and Plague&mda...
Source: TIME: Health - July 11, 2023 Category: Consumer Health News Authors: Dan Werb Tags: Uncategorized COVID-19 feature freelance Source Type: news

Effectiveness of Monovalent mRNA COVID-19 Vaccine During Omicron Effectiveness of Monovalent mRNA COVID-19 Vaccine During Omicron
This report shows that monovalent mRNA COVID-19 vaccines continued to provide substantial protection against COVID-19-associated IMV and death, even during the period of the Omicron variant.Morbidity & Mortality Weekly Report
Source: Medscape Allergy Headlines - July 7, 2023 Category: Allergy & Immunology Tags: Public Health & Prevention Journal Article Source Type: news

The Conspirituality of Robert F. Kennedy Jr.
This article has been adapted from Chapter 23 of Conspirituality: How New Age Conspiracy Theories Became a Health Threat by Derek Beres, Matthew Remski, and Julian Walker. Copyright © 2023. Available from PublicAffairs, an imprint of Hachette Book Group, Inc.
Source: TIME: Health - July 5, 2023 Category: Consumer Health News Authors: Derek Beres, Matthew Remski, and Julian Walker Tags: Uncategorized freelance politics Source Type: news

Adverse events following immunisation (AEFI) of COVISHIELD vaccination among healthcare workers in Ghana
Conclusion The results of our study indicate a high incidence of non-serious AEFI and the rare occurrence of serious AEFI after COVISHIELD vaccination in healthcare workers. The rate of AEFI was higher after the first dose than after the second dose. Sex, age, previous SARS-CoV-2 infection, allergies and comorbidity were not significantly associated with the onset and duration of AEFI.
Source: BMJ Open - June 28, 2023 Category: General Medicine Authors: Marfoh, K., Samba, A., Okyere, E., Acheampong, F., Owusu, E., Darko, D. N. A., Zakariah, J., Mensa, H., Aidoo, E., Mohammed, Y. Tags: Open access, Immunology (including allergy), COVID-19 Source Type: research

COVID-19, Coronavirus Vaccines, and Possible Association with Lipsch ütz Vulvar Ulcer: A Systematic Review
In conclusion, COVID-19 and immunization against SARS-CoV-2 add to Epstein-Barr virus as plausible triggers of Lipschütz genital ulcer.
Source: Clinical Reviews in Allergy and Immunology - June 26, 2023 Category: Allergy & Immunology Source Type: research

Vaccination approach in patients with an allergic reaction to COVID-19 vaccines or at risk of developing allergic reactions
CONCLUSIONS: Considering the potentially life-saving benefits of vaccination in a global pandemic environment, it is a safe and effective method to administer vaccines to at-risk patients using desensitization or split dosing techniques, based on their sensitivity status determined through a PEG skin test. This approach allows for the avoidance of preventing access to vaccines, while still ensuring the safety of patients.PMID:37345399 | DOI:10.5578/tt.20239920
Source: Tuberkuloz ve Toraks - June 22, 2023 Category: Respiratory Medicine Authors: Şeyma Özden Fatma Merve Tepetam Özge Atik Source Type: research

Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients
Vaccine. 2023 Jun 15:S0264-410X(23)00714-4. doi: 10.1016/j.vaccine.2023.06.039. Online ahead of print.ABSTRACTBasophil activation test (BAT) can tackle multiple mechanisms underlying acute and delayed hypersensitivity to drugs and vaccines and might complement conventional allergy diagnostics but its role in anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine-related hypersensitivity is ill-defined. Therefore, 89 patients with possible hypersensitivity (56 % with delayed mucocutaneous manifestations) to anti-SARS-CoV-2 vaccines were tested with BAT for Macrogol 3350, DMG-PEG 2000, PEG 20000, polysorba...
Source: Vaccine - June 22, 2023 Category: Allergy & Immunology Authors: Patrizia Pignatti Giuseppe Alvise Ramirez Marco Russo Paolo Marraccini Serena Nannipieri Chiara Asperti Fabrizio Della Torre Antonio Tiri Beatrice Maria Gatti Antonella Gurrado Antonio Meriggi Giovanni Benanti Maria Bernadette Cilona Paolo Pigatto Samuele Source Type: research

Vaccination approach in patients with an allergic reaction to COVID-19 vaccines or at risk of developing allergic reactions
CONCLUSIONS: Considering the potentially life-saving benefits of vaccination in a global pandemic environment, it is a safe and effective method to administer vaccines to at-risk patients using desensitization or split dosing techniques, based on their sensitivity status determined through a PEG skin test. This approach allows for the avoidance of preventing access to vaccines, while still ensuring the safety of patients.PMID:37345399 | DOI:10.5578/tt.20239920
Source: Tuberkuloz ve Toraks - June 22, 2023 Category: Respiratory Medicine Authors: Şeyma Özden Fatma Merve Tepetam Özge Atik Source Type: research

Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients
Vaccine. 2023 Jun 15:S0264-410X(23)00714-4. doi: 10.1016/j.vaccine.2023.06.039. Online ahead of print.ABSTRACTBasophil activation test (BAT) can tackle multiple mechanisms underlying acute and delayed hypersensitivity to drugs and vaccines and might complement conventional allergy diagnostics but its role in anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine-related hypersensitivity is ill-defined. Therefore, 89 patients with possible hypersensitivity (56 % with delayed mucocutaneous manifestations) to anti-SARS-CoV-2 vaccines were tested with BAT for Macrogol 3350, DMG-PEG 2000, PEG 20000, polysorba...
Source: Vaccine - June 22, 2023 Category: Allergy & Immunology Authors: Patrizia Pignatti Giuseppe Alvise Ramirez Marco Russo Paolo Marraccini Serena Nannipieri Chiara Asperti Fabrizio Della Torre Antonio Tiri Beatrice Maria Gatti Antonella Gurrado Antonio Meriggi Giovanni Benanti Maria Bernadette Cilona Paolo Pigatto Samuele Source Type: research